Cleveland Clinic Center for Continuing Education reserves the right to cancel or postpone an activity at our sole discretion. In the unlikely event that this occurs, any registration fee(s) paid will be refunded. Be advised that Cleveland Clinic is not responsible for related costs including penalties incurred as a result of any cancellations or changes.
Description/Overview
This in-person educational program will provide updates in diagnoses, treatments, and cutting-edge research on gastrointestinal (GI) disorders. Included are didactic lectures and case-based panel discussions from world-renowned gastroenterology specialists. Featured are a variety of topics in the areas of Neurogastroenterology & Motility, General GI, Swallowing Center, Therapeutic Advanced Endoscopy, Liver Diseases, and Inflammatory Bowel Diseases as comprehensive reviews of gastroenterology.
Who Should Attend?
This course is designed for practicing physicians, fellows, residents, nurses, physician assistants, nurse practitioners, and other healthcare professionals in gastroenterology, internal medicine, family practice, and gastrointestinal surgery.
Objectives
- Review behavioral therapy options for patients with gastroenterology diseases
- Discuss practical tips for feeding tubes
- Examine what is new and old in treating patients with Celiac Disease
- Uncover what practical tips, what is new and out in acute and chronic pancreatitis
- Identify advanced therapies for Barrett’s Disease
- Determine the difficulties of Hepatitis B
- Recognize the changing landscapes and paradigm in Primary Biliary Cholangitis
- Summarize the management of Pouch disorders and dietary management of IBD
- Analyze treatments for Fibrostenotic Crohn’s Disease
Testimonials From Past Attendees
Feedback for presenters...
“Excellent info and presenters, really enjoyed this one.”
“All were very informative, and information provided was organized well in an easy-to-understand format.”
Impacts as a member of the healthcare team…
“Increased my knowledge on GI and liver disorders; Good networking.”
“Guidelines with IBD biologic use, clinical trial data – very helpful. Testing for liver disease, discussion on obesity epidemic in the
US - very helpful; anxiety and depression in IBD and the need for more support from colleagues in mental health.”
“I had not considered ordering a PET scan for patients with IgG4-related disease; I thought it was interesting in the provided case in that it provided more information regarding disseminated disease. I also needed a review of the new nomenclature for metabolic associated liver disease
(etc.) so that I may document properly…”